Nozaki, Kenji http://orcid.org/0000-0002-6208-1227
Sugahara, Hiroyuki
Ueda, Shuji
Ishikawa, Jun
Karasuno, Takahiro
Iida, Masato
Kamae, Tsuyoshi
Moriyama, Yasuhiro
Kawakami, Manabu
Kosugi, Satoru
Nakagawa, Masashi
Azenishi, Yasuhiko
Sakaniwa, Ryoto
Kitamura, Tetsuhisa
Shibayama, Hirohiko
Funding for this research was provided by:
Eisai
Article History
Received: 1 February 2021
Revised: 7 April 2021
Accepted: 7 April 2021
First Online: 13 April 2021
Declarations
:
: Our study group received research funding from Eisai Co. Kenji Nozaki received personal fees from Chugai and Celgene outside the submitted work. Satoru Kosugi received personal fees from Novartis, Bristol-Myers Squibb, Eisai, Takeda, Kyowa Kirin, Chugai, Ono, Nippon Shinyaku, Janssen, Celgene, and Pfizer outside the submitted work. Hirohiko Shibayama received Grants and personal fees from Eisai during the conduct of the study; Grants and personal fees from Takeda, Ono, Sumitomo Dainippon Pharma, Mundi Pharma, and Nippon Shinyaku; Grants from Teijin, MSD, Shionogi, and Taiho; personal fees from Novartis, Janssen, Celgene, Chugai, Kyowa Kirin, Otsuka, AstraZeneca, Avvie, Daiichi Sankyo, Fujimoto, Sanofi, Bristol-Meyers Squibb and Pfizer outside the submitted work.